comparemela.com

Latest Breaking News On - Driehaus capital management - Page 4 : comparemela.com

Blue Bird Co. (NASDAQ:BLBD) Given Average Recommendation of "Buy" by Brokerages

Shares of Blue Bird Co. (NASDAQ:BLBD – Get Free Report) have received an average rating of “Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12 month price objective among analysts that have updated their coverage on […]

Canada
United-states
Britton-smith
Roth-mkm
Phil-horlock
Craig-hallum
Needham-company
Marshall-wace
Driehaus-capital-management
Kennedy-capital-management
Blue-bird-co
Blue-bird-corporation

Jefferies Financial Group Begins Coverage on Aerovate Therapeutics (NASDAQ:AVTE)

Jefferies Financial Group started coverage on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research note issued to investors on Monday morning, Marketbeat.com reports. The firm issued a buy rating and a $65.00 price target on the stock. Separately, Wells Fargo & Company initiated coverage on shares of Aerovate Therapeutics in a research […]

United-states
Alps
Switzerland-general
Switzerland
Swiss
Marinus-verwijs
Ralph-niven
Alps-advisors-inc
Silverarc-capital-management
Aerovate-therapeutics-inc
Highvista-strategies
Swiss-national-bank

Primoris Services (NASDAQ:PRIM) Hits New 12-Month High at $41.99

Primoris Services Co. (NASDAQ:PRIM – Get Free Report)’s stock price hit a new 52-week high on Wednesday . The company traded as high as $41.99 and last traded at $41.70, with a volume of 103696 shares trading hands. The stock had previously closed at $41.14. Analyst Ratings Changes Several research analysts recently weighed in on […]

Canada
United-states
Wellington
New-zealand-general
New-zealand
Travisl-stricker
Johnp-schauerman
Insider-activity-at-primoris-services
News-ratings-for-primoris-services-daily
Nasdaq
Primoris-services-co

Astria Therapeutics (NASDAQ:ATXS) Shares Gap Up Following Analyst Upgrade

Astria Therapeutics (NASDAQ:ATXS) Shares Gap Up Following Analyst Upgrade
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Christopher-morabito
Jefferies-financial-group
Perceptive-advisors
Driehaus-capital-management
Securities-exchange-commission
Sphera-funds-management
Astria-therapeutics-inc
Affinity-asset-advisors
Nasdaq
Jump-financial
Perceptive-advisors-llc

Tyra Biosciences' (TYRA) "Outperform" Rating Reaffirmed at Wedbush

Wedbush reissued their outperform rating on shares of Tyra Biosciences (NASDAQ:TYRA – Free Report) in a research note published on Thursday, Benzinga reports. Wedbush currently has a $28.00 target price on the stock. Other equities analysts have also issued reports about the stock. HC Wainwright reaffirmed a buy rating and issued a $23.00 price objective […]

United-states
America
Daniel-bensen
Tyra-biosciences
Securities-exchange-commission
Exchange-traded-concepts
Tyra-biosciences-inc
Driehaus-capital-management
Corton-capital-inc
Simplex-trading
York-mellon-corp
Free-report

vimarsana © 2020. All Rights Reserved.